MAPT and Alzheimer disease: Levels of CSF T-tau and P-tau were found to be higher in the three cognitively impaired DM1 patients compared to noncognitively impaired DM1 patients, but with a mean value lower than that typically observed in AD patients and more similar to other tauopathies such as FTD.